Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 15, 2017
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - December 15, 2017

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/15/17 - "Dermal Filler Based on Crosslinked Hyaluronic Acid and Carboxymethyl Cellulose Lubricant" in Patent Application Approval Process (USPTO 20170333596)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors HAGEDORN, NADINE; STRAGIES, ROLAND; VILLAIN, FRANCK; BELKOVI, LUBIN; EL-BANNA, RADIA, filed on November 12, 2015, was made available online on November 30, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This pate
12/15/17 - ACEA Biosciences and Ncardia Announce Global Partnership to Provide Solutions for Cardiac Drug Discovery and Cardiac Safety Assessment
By a News Reporter-Staff News Editor at Drug Week ACEA Biosciences, a pioneer and leader in label-free real-time cell analysis instrumentation, and Ncardia, a leading expert in human cardiovascular stem cell technology, disease modelling and cell-based assay products and services, announced that they have established a global partnership to provi
12/15/17 - Agendia's MammaPrint Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code
By a News Reporter-Staff News Editor at Insurance Weekly News Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces that its MammaPrint 70- Gene Breast Cancer Risk- of-Recurrence Test has received a favorable payment determination for CY 2018 from the Centers for Medicare and Medicaid Services 1 for
12/15/17 - Arbutus Biopharma Corp. Files SEC Form 8-K, Current Report: (Nov. 27, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arbutus Biopharma Corp. was posted on November 27, 2017. The SEC file number is 0001171843-17-007282.. A U.S. Securities and Exchange Commission filing is a for
12/15/17 - Astellas to Present New Data Exploring Gilteritinib in Newly Diagnosed Acute Myeloid Leukemia AML Patients at the 2017 American Society of Hematology...
By a News Reporter-Staff News Editor at Drug Week Astellas Pharma Inc. announced new data in acute myeloid leukemia research, including preliminary results from a Phase 1 study of the investigational agent gilteritinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed AML, it will present at the 2017 Am
12/15/17 - Can-fite Biopharma Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Nov. 27, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Can-fite Biopharma Ltd. was posted on November 27, 2017. The SEC file number is 0001213900-17-012582.. A U.S. Securities and Exchange Commission filing is a for
12/15/17 - Center for Immunobiology and Vaccine Development Describes Findings in Chlamydia trachomatis (Chlamydia trachomatis regulates growth and development...
Center for Immunobiology and Vaccine Development Describes Findings in Chlamydia trachomatis. According to news reporting out of Oakland, California, by NewsRx editors, research stated, " Chlamydia trachomatis is a Gram-negative obligate intracellular pathogen of humans that causes significant morbidity from sexually transmitted and ocular diseases
12/15/17 - Cti Biopharma Corp. Files SEC Form 8-K, Current Report: (Nov. 28, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on November 28, 2017. The SEC file number is 0000891293-17-000127.. A U.S. Securities and Exchange Commission filing is a formal
12/15/17 - Cti Biopharma Corp. Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Nov. 28, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on November 28, 2017. The SEC file number is 0000891293-17-000126.. A U.S. Securities and Exchange Commission filing is a formal
12/15/17 - Cti Biopharma Corp. Files SEC Form PRE 14A, Other Preliminary Proxy Statements: (Nov. 28, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Cti Biopharma Corp. was posted on November 27, 2017. The SEC file number is 0000891293-17-000122.. A U.S. Securities and Exchange Commission filing is a formal
12/15/17 - Cuba exports medicine to dozens of countries. It would like the U.S. to be one of them [The Miami Herald]
Dec. 14 HAVANA Cuba now exports vaccines, diagnostic kits and drugs developed by its Center for Genetic Engineering and Biotechnology the largest research center on the island to 51 countries. For cash-strapped Cuba, the equation is simple: The United States is not only close but has an enormous number of patients that could benefit from dr
12/15/17 - Cyclica Launches Ligand Express?, a Disruptive Cloud-Based Platform to Revolutionize Drug Discovery
By a News Reporter-Staff News Editor at Drug Week It is taking longer, and costing more to bring fewer drugs to the market- the process can take upwards of 14 years and cost $2.5 bn. Pharmaceutical companies are seeking productivity gains in the discovery and development of new therapeutics, and are now turning towards digital technologies.
12/15/17 - EU and UK Life Sciences Industry Issue Joint Policy Document on Brexit
Today, the Association of the European Self-Medication Industry, the ABPI, the BioIndustry Association, the British Generics Manufacturers Association, European Biopharmaceutical Enterprises, the European Federation of Pharmaceutical Industries and Associations, the European Confederation of Pharmaceutical Entrepreneurs, the European...
12/15/17 - FDA approves Abilify trackable pill from Otsuka
US regulators have approved the first pill that can be digitally tracked through the body. The Abilify MyCite aripiprazole tablets- for treating schizophrenia and manic episodes-have an ingestible sensor embedded inside them that records that the medication has been taken. Mitchell Mathis, from the Food and Drug Administration, said: Being able
12/15/17 - Findings from National Organization for Drug Control and Research Update Knowledge of Dopaminergic Antiparkinsonism Agents (Thermal decomposition...
According to news reporting out of Giza, Egypt, by NewsRx editors, research stated, "The thermal decomposition kinetics of entacapone have been investigated via thermogravimetric analysis under non-isothermal and isothermal conditions which provide useful stability information for their processing in the pharmaceutical industry and also for...
12/15/17 - Findings in Drug Delivery Reported from University of Cambridge (Screening for new pharmaceutical solid forms using mechanochemistry: A practical...
Findings in Drug Delivery Reported from University of Cambridge. Our news editors obtained a quote from the research from the University of Cambridge, "This contribution focuses on mechanochemistry as a versatile approach for discovering new and alternative solid forms. The news editors report that additional information may be obtained by contacti
12/15/17 - Global Downstream Processing Market to Reach Nearly US $26 Bn in Revenue by 2022: North America is set to dominate the global downstream processing market in terms of revenue.
Albany, NY 12/14/2017 The global downstream processing market is likely to witness steady growth during the forecast period 2017-2022 on account of a host of factors on which a new research report offers holistic insights. North America is likely to be the leading market for downstream processing globally. The market in North America will be
12/15/17 - Global Poultry Pharmaceuticals Market Research, Trends, Survey and Forecast 2016-2024
Albany, NY 12/14/2017 This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of poultry pharmaceuticals such as drugs, vaccines, and feed addi
12/15/17 - Hemispherx Biopharma Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Nov. 27, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Hemispherx Biopharma Inc. was posted on November 27, 2017. The SEC file number is 0001493152-17-013804.. A U.S. Securities and Exchange Commission filing is a f
12/15/17 - InDex Pharmaceuticals Reports New Mechanism of Action Data for Cobitolimod
By a News Reporter-Staff News Editor at Drug Week InDex Pharmaceuticals Holding AB announced new scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate. The findings show that cobitolimod can modulate the immune system in ulcerative colitis by balancing the mucosal Th17/Treg cell response. Cobitolimod has...
12/15/17 - Integrated Biopharma Inc. Files SEC Form 8-K, Current Report: (Nov. 28, 2017)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Integrated Biopharma Inc. was posted on November 27, 2017. The SEC file number is 0001437749-17-019834.. A U.S. Securities and Exchange Commission filing is a f
12/15/17 - Investigators at Institute of Pharmacy Report Findings in Drug Delivery Systems (Development of pre-activated alpha-cyclodextrin as a mucoadhesive...
Investigators at Institute of Pharmacy Report Findings in Drug Delivery Systems. According to news originating from Innsbruck, Austria, by NewsRx correspondents, research stated, "The study was designed to synthesize and characterize pre-activated alpha-cyclodextrin derivatives as mucus adhering excipients for intra-vesical drug delivery.
12/15/17 - Investigators at Medical Center Discuss Findings in Drug Delivery Systems (Ultrahigh field MR imaging of a subconjunctival anti-glaucoma drug...
Investigators at Medical Center Discuss Findings in Drug Delivery Systems. By a News Reporter-Staff News Editor at Drug Week Investigators discuss new findings in Drugs and Therapies- Drug Delivery Systems. According to news originating from Rostock, Germany, by NewsRx correspondents, research stated, "Local drug delivery systems have become a fa
12/15/17 - Investigators at Public Hospital System Detail Findings in Drug Delivery Systems (Cyanine derivative as a suitable marker for thermosensitive in situ...
By a News Reporter-Staff News Editor at Drug Week Data detailed on Drugs and Therapies- Drug Delivery Systems have been presented. According to news reporting originating in Paris, France, by NewsRx journalists, research stated, "Buccal administration route is a promising way for a large number of drugs exhibiting a low oral bioavailability.
12/15/17 - Issuance of Priority Review Voucher; Rare Pediatric Disease Product
The Federal Food, Drug, and Cosmetic Act, as amended by the Food and Drug Administration Safety and Innovation Act, authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher.
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415